REYON PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss
The total revenue of 102460 for the last quarter is 38.85 B KRW, and it's 3.77% higher compared to the previous quarter. The net income of Q4 23 is -989.36 M KRW.